Equity Details
Price & Market Data
Price: $39.56
Daily Change: -$0.0306 / 0.08%
Daily Range: $39.56 - $39.65
Market Cap: $6,128,814,080
Daily Volume: 1,524,360
Performance Metrics
1 Week: -0.15%
1 Month: 0.10%
3 Months: 68.20%
6 Months: 79.07%
1 Year: 201.2%
YTD: 58.38%
About Centessa Pharmaceuticals plc (CNTA)
Financial insights into Centessa Pharmaceuticals plc (CNTA). Current price: 39.56, daily change: -$0.0306 / 0.08%. Market cap: 6,128,814,080. Performance metrics across all timeframes are updated.
Company Details
Employees: 118
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United Kingdom
Details
Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.